Related Experiment Video

Updated: Aug 25, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair

Shakir Ali1, Derek A Mann

  • 1Division of Infection, Inflammation and Repair, Southampton University Hospital, Southampton, UK.

Cell Biochemistry and Function
|March 18, 2004
PubMed

Insights

Nuclear factor-kappa B (NF-kappaB) activation is crucial for cell signaling during stress. Modulating this pathway offers potential for treating diseases and promoting tissue repair.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Immunology

Background:

  • Transcription factors are key regulators of cellular responses.
  • Nuclear factor-kappa B (NF-kappaB) is a critical transcription factor involved in stress response, inflammation, and apoptosis.
  • NF-kappaB signaling is implicated in various physiological and pathological processes.

Purpose of the Study:

  • To review the diverse conditions where NF-kappaB activation is vital under stress.
  • To explore the therapeutic potential of modulating NF-kappaB signaling pathways.
  • To highlight NF-kappaB's role in disease treatment and tissue repair.

Main Methods:

  • Literature review of studies on NF-kappaB activation pathways.
  • Analysis of NF-kappaB's role in different stress-induced cellular events.
  • Synthesis of information on therapeutic strategies targeting NF-kappaB.

Main Results:

  • NF-kappaB activation is a common response to various stressors including infection and inflammation.
  • The pathway is linked to critical cellular processes like apoptosis and tissue regeneration.
  • Evidence suggests NF-kappaB modulation can impact disease progression and healing.

Conclusions:

  • NF-kappaB signaling is a central mediator of cellular stress responses.
  • Targeting NF-kappaB activation presents a promising therapeutic avenue for numerous diseases.
  • Further research into NF-kappaB modulation could advance treatments for inflammatory conditions and enhance tissue repair.

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...